Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
FRLN was delisted on the 16th of February, 2024.
12 hedge funds and large institutions have $9.9M invested in Freeline Therapeutics Holdings plc American Depositary Shares in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 2 closing their positions.
580% more capital inflows, than outflows
Capital inflows: $1.78M | Capital outflows: $262K
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
9% more funds holding
Funds holding: 11 → 12 (+1)
7.85% more ownership
Funds ownership: 45.43% → 53.28% (+7.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.47M |
| 2 |
CHI Advisors
New York
|
+$257K |
| 3 |
Morgan Stanley
New York
|
+$29.9K |
| 4 |
Renaissance Technologies
New York
|
+$17.8K |
| 5 |
Harbor Capital Advisors
Chicago,
Illinois
|
+$7.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tang Capital Management
San Diego,
California
|
-$258K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$4K |
| 3 |
Syncona Portfolio
St Peter Port,
Guernsey
|
-$4 |
FRLN Hedge Fund Activity: Q3 2023 in Review
12 of the 6,316 institutional investors tracked by Wall St. Rank reported a position in Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) for Q3 2023, worth a combined $9.9M — up 94% from $5.09M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new FRLN positions and 2 closed out — a net gain of 1 holder — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $1.47M. The largest seller was Tang Capital Management, exiting entirely with an estimated $258K sold.
- 12 institutional investors held Freeline Therapeutics Holdings plc American Depositary Shares (FRLN) as of Q3 2023, up from 11 in Q2 2023.
- Funds reported $9.9M of Freeline Therapeutics Holdings plc American Depositary Shares stock for Q3 2023, up 94% quarter-over-quarter.
- 3 funds opened new Freeline Therapeutics Holdings plc American Depositary Shares positions in Q3 2023 and 2 closed out, a net change of +1 holder.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares buyer in Q3 2023 was Millennium Management, an estimated $1.47M added.
- The largest Freeline Therapeutics Holdings plc American Depositary Shares seller in Q3 2023 was Tang Capital Management, an estimated $258K sold.
Based on aggregated 13F filings for Q3 2023.